Dr. Evan Hayward Goulding, MD, PhD

Dr. Goulding practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Goulding's NPI, 1063645315, was assigned on September 2, 2009. Dr. Goulding graduated from University of California, San Francisco School of Medicine in 1996. Dr. Goulding holds Illinois license 036.126710.

Dr. Goulding's primary practice is Northwestern Medical Group, at 446 E Ontario St 100 Dept Of Psychiatry, Chicago, IL 60611-4418. The practice phone is (312) 695-5060.

Dr. Goulding's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Goulding is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goulding practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Goulding's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Goulding's licenses on file in 2 states: Illinois and California.

CMS data shows 376 Medicare services from Dr. Goulding across 5 procedure codes in 2024, for 50 Medicare patients. Medicare paid $27,797 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Goulding in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have anxiety, and 75% have mood disorders. 44% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goulding's median patient age at 58, with 65% women.

In 2024, Dr. Goulding wrote 1,058 Medicare Part D claims for 83 patients. 98% of them were for generic drugs. CMS names the drug for 957 of them, across 26 drugs with 11 or more claims each, at $56,266 in total drug cost. In 2023, CMS named 753 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Goulding for performance year 2024, reported through an alternative payment model (APM). Dr. Goulding accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goulding as offering telehealth.

Dmand AI links 16 papers to Dr. Goulding, published from 2011 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Mice, Inbred C57BL, Motor Activity and Activities of Daily Living. Dr. Goulding has published most often in JMIR Form Res. Dr. Goulding's most frequent co-authors are Stephen J. Bonasera, MD, Laurence H. Tecott, MD and Andrew Harrison Bank, MD.

Dmand AI links Dr. Goulding to 1 clinical trial. Conditions studied include Bipolar and Related Disorders and Bipolar Disorder.

CMS Open Payments shows 3 general payments to Dr. Goulding from 1 drug or device company from 2019 to 2021. Consulting fees make up the largest share, 97% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $3,916.

Dr. Goulding graduated from University of California, San Francisco School of Medicine in 1996.